Keynote presentations are always a highlight of the #ACSNLCRT Annual Meeting. As #NLCRT2024 approaches, we're honored to introduce this year's keynote speakers. Chris T. Pernell, MD, MPH, FACPM serves as Director of the NAACP Center for Health Equity. Her work focuses on health justice, community-based advocacy, and population-wide health promotion and disease prevention. We're looking forward to the critical insights she'll share on advancing health equity across the lung cancer continuum. Dr. Pasi J?nne, Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, will anchor a session on the #LungCancer treatment landscape. As a co-discoverer of EGFR mutations, Dr. J?nne's work has transformed the treatment of lung cancer, earning him the 2024 Medal of Honor from the American Cancer Society. To learn more about our incredible speakers and view the full meeting agenda, visit https://bit.ly/3NvqoA4
Biodesix, Inc.
医院和医疗保健
Louisville，Colorado 16,460 位关注者
Leader in Clinical Diagnostic Testing & Biopharma Services. ***INC. 2024 Best Workplaces***
关于我们
A leading diagnostic solutions company with five Medicare-covered tests for the lung cancer (oncology) healthcare continuum. Partnering with BioPharma companies with our unique portfolio of patented technologies, science, and processes. INC. 2024 Best Workplaces #proteomics #genomics #liquidbiopsy #bdsx #biodesix #lungcancer #biopharma #lifesciences #diagnostics
- 网站
-
https://www.biodesix.com
Biodesix, Inc.的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 201-500 人
- 总部
- Louisville，Colorado
- 类型
- 上市公司
- 创立
- 2005
- 领域
- Molecular Diagnostics、Predictive, Prognostic and Mutation Tests、Companion Diagnostics、Mass Spectrometry Analysis of Biological Samples、oncology、lung cancer、lung disease、cancer diagnostics、biomarkers、liquid biopsy、ddPCR、Non-Small Cell Lung Cancer、Lung Nodules、Nodule Management、Proteomics、Artificial Intelligence、Genomic Testing、Clinical Trials、Biopharma Services、genomics和multi-omics
地点
Biodesix, Inc.员工
-
Natalie St. Denis, B. Commerce, MBA
Director, Corporate Marketing, Branding, & Communications
-
Angela Plonczyk
Biodesix Pulmonary Consultant Sales Representative - Lung Cancer Diagnostic Testing & Biopharma Services
-
Lance Austin, MBA
-
Jennifer Josfan
Results-Driven Regional Account Manager ? Building strategic relationships & driving new revenue-generating contracts | Account Management |…
动态
-
à l'avant-garde des essais cliniques en médecine de précision pour le cancer,?l'Institut de recherche du Centre universitaire de santé McGill teste une nouvelle thérapie néoantigénique individualisée basée sur la technologie de l'ARN messager (similaire à celle utilisée dans les vaccins à ARNm pour la COVID-19)?pour traiter la forme la plus commune de cancer du poumon. ? Nos patients sont les premiers au Canada, et parmi les premiers au monde, à y avoir accès, grace à la mobilisation de plusieurs équipes cliniques du CUSM et au leadership du Dr Jonathan Spicer, chirurgien thoracique à l'H?pital général de Montréal du CUSM, scientifique au sein du programme de recherche sur le cancer à L’Institut et directeur médical du Réseau d'oncologie thoracique de McGill. ? https://lnkd.in/eEuqZ8ir ? *** ? At the forefront of clinical trials in precision cancer medicine,?RI-MUHC | Research Institute of the MUHC | #rimuhc is testing a novel individualized neoantigen therapy based on mRNA technology - similar to that used in mRNA COVID-19 vaccines-?to treat the most common form of lung cancer. ? Our patients are the first in Canada, and among the first in the world, to enroll in these trials, thanks in part to the mobilization of several MUHC clinical teams and to the leadership of Dr. Jonathan Spicer, thoracic surgeon at the Montreal General Hospital of the MUHC, Scientist in the Cancer Research Program at The Institute and Medical Director of the McGill Thoracic Oncology Network. https://lnkd.in/eEuqZ8ir La Presse La Presse Canadienne Jean-Benoit Legault #TheInstitute #LInstitut
-
-
As Lung Cancer Awareness Month comes to a close, we?reflect on our team's efforts to support patients and healthcare providers in advancing the early detection of lung cancer. Thank you to everyone who has helped to spread?the?facts about lung cancer throughout the?month and beyond. #Biodesix #Diagnostics #LifeSciences #LungCancer #LungCancerAwarenessMonth #LCAM #AnyoneWithLungs #LungCancerScreening #EarlyDetection
-
-
Air pollution accounts for an estimated 15% of lung cancer deaths globally. See the International Association for the Study of Lung Cancer's post about this issue. #Diagnostics #LifeSciences #LungCancer #LungCancerAwarenessMonth #LCAM #AnyoneWithLungs?#Biodesix
???? Did you know? The World Health Organization says air pollution contributes to an estimated 15% of lung cancer deaths globally. Reducing exposure to pollutants and improving air quality are essential steps in cancer prevention. Let's work together to advocate for cleaner air and healthier communities! #LCAM24 #CleanAir #HealthForAll #LCSM
-
-
Brooke Salisbury had meaningful experiences this Lung Cancer Awareness Month. Starting with the American Lung Association's Lung Force Run Walk 2024 in Charleston, SC, and finishing at the Prisma Health LCAM event. #Biodesix #Diagnostics #LifeSciences #LungCancer #LungCancerAwarenessMonth #LCAM #AnyoneWithLungs
-
-
-
-
-
+1
-
-
Thank you to Andrew McPherson for sharing your survivor's perspective at today's team event?in support of?LCAM. Your passionate activism to improve early detection?is?truly admirable. ? Read his story here:?https://lnkd.in/gw38Vmhg ? #Biodesix #Diagnostics #LifeSciences #LungCancer #LungCancerAwarenessMonth #LCAM #AnyoneWithLungs #LungCancerScreening #EarlyDetection
-
-
Lung cancer is not just a smoker's disease. See LUNGevity Foundation's post below that dispels common misconceptions about lung cancer.?#LungCancerAwareness #AnyoneWithLungs #LCAM
It is a common misconception that only people who smoke get lung cancer. It is estimated that 65% of new lung cancer diagnoses occur in people who have no smoking history or are former smokers. We need your help this #LungCancerAwarenessMonth to share the facts with your community. Let friends and family know #AnyoneWithLungs can get lung cancer. Get started by visiting lungevity.org/lcam to spread awareness throughout November. #LCAM #lcsm #lungcancer #transforminglungcancer
-
-
Congratulations to the Pulmonary team of Carle Health Methodist for reaching this milestone! #Biodesix #Diagnostics #Biomarkers #LifeScience #Pulmonary #LungCancer
Proud to partner with this Pulmonology team of Carle Health Methodist in Peoria Illinois! They have exceeded 200 Nodify Lung tests to help risk stratify their low to moderate risk lung nodule patients! ?????? #Biodesix #CatchCancerEarly Biodesix, Inc.
-
-
Biodesix is honored to be recognized as one of the Top 100 Healthcare Technology Companies of 2024 by The Healthcare Technology Report! Thank you to our dedicated employees who made this achievement possible. #Biodesix #Diagnostics #LifeScience
The Top 100 Healthcare Technology Companies of 2024 The Healthcare Technology Report is pleased to announce its annual awards for The Top 100 Healthcare Technology Companies. This year’s awardees were selected based on a methodical review of nomination submissions as well as further in-depth research into each candidate’s products and solutions, corporate track record, management team caliber, and organizational depth, among other factors. Regeneron, Medtronic, Henry Schein, Access Healthcare, LifeLabs Medical Laboratory Services, PHC Holdings Corporation, Integra LifeSciences, Lumeris, Omnicell, Globus Medical, Jazz Pharmaceuticals, Penumbra, PCI Pharma Services, Corza Medical, Aspen Medical, LivaNova, embecta, HONOR Technology, Privia Health, CareDx, Merit Medical Systems, Castle Biosciences, Endologix, Blueprint Medicines, Denali, BillionToOne, Spring Health, Ardelyx, Tebra, Zynex Medical, Tandem Diabetes Care, Biodesix, Rocket Pharma, Consensus Cloud Solutions, argenx, Rightway, Insilico Medicine, Kipu Health, Veradigm, Sutro Biopharma, SS Innovations, Promaxo, Caris Life Sciences, Burlington Medical, Phathom Pharmaceuticals, Trusted Health, Amwell, BenchSci, Heidi Health, ELEGEN., Natus Medical, Angle Health, Microbiologics, CodaMetrix, PTC Therapeutics, Livara Health, SAB BIO, Nym, Axxess, Kontakt.io, Simple App, Abcuro, Inc, Maven Clinic, Arcturus Therapeutics, Welldoc, Ostro, Sword Health, Scientist.com, Orca Bio, Bamboo Health, Omada Health, Relias, Cynerio, KLOwen Ortho, Iovance Biotherapeutics, OrthAlign, DermaSensor, Inc., PartsSource, Viz.ai, Outset Medical, Visualutions, Forward Advantage, Codonics, Intellia Therapeutics, CliniComp, Chordline Health, Jelvix, HeartFlow, Intelligencia AI, Quris AI, HMNC Brain Health, Carrot Fertility, SimpleTherapy, Casana, Vizzia Technologies, Revolution Medicines, Noah Medical, RxSight, Kestra Medical Technologies and Allurion Technologies. To view the full list visit our website: https://lnkd.in/gdphXRAS Nominate a Top Women Leaders and Top CEOs in Healthcare Technology of 2024 at https://lnkd.in/d9crSvH Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #biotech #medicaldevices #consumerhealth #technology
-
-
Kimberly Le, PharmD, MS, MBA presented?six?posters?with economic analysis for biomarkers in lung nodule management?at the ISPOR Europe 2024 conference in Barcelona, Spain. Thank you to all who attended the poster sessions.? ? See all abstract information here: https://lnkd.in/g5N--MCv ? #Biodesix #Diagnostics #LifeSciences #ISPOREurope
-